Quadrant Capital Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-434
Closed -$2.25K 2811
2024
Q3
$2.25K Buy
+434
New +$2.25K ﹤0.01% 2481
2024
Q2
Sell
-400
Closed -$1.97K 2780
2024
Q1
$1.97K Sell
400
-198
-33% -$974 ﹤0.01% 2516
2023
Q4
$5.26K Buy
598
+455
+318% +$4K ﹤0.01% 2266
2023
Q3
$1.64K Sell
143
-22
-13% -$252 ﹤0.01% 2434
2023
Q2
$4.18K Buy
165
+7
+4% +$177 ﹤0.01% 2248
2023
Q1
$5.09K Sell
158
-2
-1% -$64 ﹤0.01% 2235
2022
Q4
$2.95K Sell
160
-56
-26% -$1.03K ﹤0.01% 2321
2022
Q3
$6K Hold
216
﹤0.01% 2109
2022
Q2
$3K Sell
216
-41
-16% -$569 ﹤0.01% 2161
2022
Q1
$5K Sell
257
-60
-19% -$1.17K ﹤0.01% 1943
2021
Q4
$5K Buy
317
+204
+181% +$3.22K ﹤0.01% 1913
2021
Q3
$3K Buy
113
+5
+5% +$133 ﹤0.01% 2086
2021
Q2
$3K Sell
108
-110
-50% -$3.06K ﹤0.01% 2054
2021
Q1
$6K Hold
218
﹤0.01% 1752
2020
Q4
$6K Hold
218
﹤0.01% 1662
2020
Q3
$5K Hold
218
﹤0.01% 1581
2020
Q2
$5K Sell
218
-6,802
-97% -$156K ﹤0.01% 1696
2020
Q1
$104K Buy
7,020
+9
+0.1% +$133 0.02% 570
2019
Q4
$111K Hold
7,011
0.01% 915
2019
Q3
$89K Buy
+7,011
New +$89K 0.01% 933
2019
Q2
Sell
-1,478
Closed -$23K 2415
2019
Q1
$23K Buy
1,478
+1,375
+1,335% +$21.4K ﹤0.01% 1506
2018
Q4
$2K Hold
103
﹤0.01% 1962
2018
Q3
$2K Hold
103
﹤0.01% 1930
2018
Q2
$2K Hold
103
﹤0.01% 1939
2018
Q1
$3K Hold
103
﹤0.01% 1751
2017
Q4
$3K Hold
103
﹤0.01% 1701
2017
Q3
$2K Hold
103
﹤0.01% 1864
2017
Q2
$2K Hold
103
﹤0.01% 1630
2017
Q1
$2K Buy
+103
New +$2K ﹤0.01% 1678